General Information of Drug (ID: DMVAP4T)

Drug Name
Camrelizumab Drug Info
Synonyms GTPL9758; SHR-1210
Indication
Disease Entry ICD 11 Status REF
Coronavirus Disease 2019 (COVID-19) 1D6Y Investigative [1]
Therapeutic Class
Antiviral Agents
Cross-matching ID
TTD Drug ID
DMVAP4T

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
HUMAN programmed cell death protein 1 (PD-1) TTVLU5N PDCD1_HUMAN Inhibitor [1]

References

1 ClinicalTrials.gov (NCT04268537) Immunoregulatory Therapy for 2019-nCoV. U.S. National Institutes of Health.